Horizon Pharma

14 results

Former UK prime minister Tony Blair is scheduled to speak Web Summit in Lisbon. Photograph: Kirsty O’Connor/PA Wire
This Week in Business: Blair to address Web Summit Lisbon

Monday Results: Mylan, Avadel Pharmaceuticals, Taro Pharmaceuticals, Avis Budget, Ferrari, Marriott International. Indicators: Irish services purcha(...)

AIB’s full-year results on Thursday mark the first annual reporting since the bank refloated. Photograph: Getty Images
Bank of Ireland results and unemployment rate

MONDAY Results: Bank of Ireland, Hammerson, Fitbit. Indicators: UK housing prices (Feb), mortgage approvals (Jan); US new home sales (Jan). TUES(...)

Vimovo is a mixture of an anti-inflammatory drug and a medicine that lessens the risk of stomach problems. Photograph: iStock
Irish-based drugmaker raises painkiller price to $3,000 in US

An Irish-domiciled pharmaceutical company has put a price tag of almost $3,000 (€2,400) on a bottle of two-in-one painkillers that can be bought separ(...)

The Web Summit: in the sunshine of its new Lisbon home – temperatures are expected to reach 21 degrees during the week – an anticipated 60,000 people are set to attend the events.
This Week: The events lined up in the business world

MONDAY Results: Avis Budget Group, Horizon Pharma, Jones Lang LaSalle, Mylan. Indicators: Irish Industrial production (Sep); Euro-zone composite, (...)

The largest mobile industry get-together on the calendar, the Mobile World Congress, has been increasing its clout every year since its more humble beginnings in 1987. Photograph: Paul Hanna/Reuters
The major business events happening this week

Monday Results: FBD Holdings, Associated British Foods (trading update), Hertz Global Holdings, Horizon Pharma, Trinity Mirror, UCP. Indicators: Ir(...)

As part of the deal, Horizon gains Procysbi, a treatment for nephropathic cystinosis, a rare metabolic disorder, as well as Quinsair, which is given to cystic fibrosis patients. Photograph: Kiyoshi Ota/Bloomberg
Dublin based Horizon to buy Raptor for $800m

Horizon Pharma has agreed to buy Raptor Pharmaceutical for about $800 million to bolster its rare-disease treatment business and expand internationall(...)

Pat McCann (left), chief executive, and John Hennessy, non-executive chairman of Dalata: the hotel group rose 1.6 per cent to €4.35 ahead of announcing the purchase of a property in Cork, where it plans to build a 121-room hotel. Photograph: Eric Luke / The Irish Times
Global stock markets edge down after weak US jobs data

Stock markets worldwide dipped yesterday after April US employment data showed the fewest jobs added in seven months, adding to concerns over economic(...)

Valeant shares fell the most in four years after politicians asked to subpoena the company for documents relating to drug price increases
Drug price query by US Democrats sees Valeant slide

Valeant Pharmaceuticals continued to lose ground yesterday after the company was targeted by US Democrats over rising drug prices. Valeant shares shed(...)

By combining, the companies could save on overlapping costs and expand sales of Depomed products, Horizon said
Depomed confirms bid increase from Dublin-based Horizon

Horizon Pharma has told Depomed that it’s prepared to increase its $2 billion offer for the company and include a cash component of as much as 25 per (...)

Timothy Walbert, Horizon Pharma chairman & CEO. The Dublin based pharma group has raised its offer to buy Depomed to $33 per share, contingent on the smaller drugmaker agreeing to start takeover talks. (Photograph: Brendan McDermid/Reuters)
Horizon Pharma raises offer for Depomed

Dublin based Horizon Pharma has raised its offer to buy Depomed to $33 per share, contingent on the smaller drugmaker agreeing to start takeover talk(...)

  • 1
  • 2
  • Next ›
  • Last »